Boniva Linked to Dead Jaw
Last Updated on June 26, 2017
Investigation Complete
Attorneys working with ClassAction.org have finished their investigation into this matter.
Check back for any potential updates and take a look at our open investigations here. The information on this page is for reference only.
At A Glance
- This Alert Affects
- Patients who suffered dead jaw while using Boniva.
- Damages
- Boniva can cause osteonecrosis, also known as dead jaw.
- Company(ies)
- Roche Laboratories
- Additional Details
- Boniva treats osteoporosis in postmenopausal women.
- Date
- The FDA released a warning about Boniva and dead jaw in Jan. 2008.
Manufactured by Roche Laboratories, Boniva treats and prevents bone loss. Boniva falls under the drug class bisphosphonates, which are largely used in fertilizers and laundry soaps. While Bonvia and similar drugs prevent bone loss, they also impede the growth of healthy osteophytes, causing a prevention of new bone growth.
Many Boniva users are developing a side effect known as osteonecrosis or dead jaw. Osteonecrosis occurs when bone tissue in the jaw does not heal after minor dental trauma, such as tooth extractors or crown placement. Some common symptoms of osteonecrosis are gum infections, swelling of the gums, loose teeth, numbness or heaviness in the jaw and exposed bone. When the jaw bone becomes exposed, it can lead to rotting, infection and possible bone death. Unfortunately, the damage cause by dead jaw cannot be fixed.
Before commenting, please review our comment policy.